165 related articles for article (PubMed ID: 817663)
1. Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli.
Zinner SH; Provonchee RB; Elias KS; Peter G
Antimicrob Agents Chemother; 1976 Apr; 9(4):661-4. PubMed ID: 817663
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of amikacin and gentamicin.
Shah RM; Heetderks G; Stille W
Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.
Parsley TL; Provonchee RB; Glicksman C; Zinner SH
Antimicrob Agents Chemother; 1977 Sep; 12(3):349-52. PubMed ID: 410362
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
Linzenmeier G; Naumann P; Neussel H; Rosin H
J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
Daschner FD; Steffens A; Langmaack H
Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli].
Nicoletti G; Russo G; Toscano MA; Gismondo MR
Boll Ist Sieroter Milan; 1979 Jan; 57(6):713-7. PubMed ID: 121911
[TBL] [Abstract][Full Text] [Related]
11. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
[TBL] [Abstract][Full Text] [Related]
12. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
Ximenes J; Hirai CK; Takenaka IM
J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
Kosakai N; Oguri T
Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
[TBL] [Abstract][Full Text] [Related]
14. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
Van Laethem Y; Husson M; Klastersky J
Antimicrob Agents Chemother; 1984 Aug; 26(2):224-7. PubMed ID: 6435515
[TBL] [Abstract][Full Text] [Related]
15. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
Ximenes J; Bassoi ON; de Menezes JP; Fry W
J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
17. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
Reynolds AV; Hamilton-Miller JM; Brumfitt W
Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
[TBL] [Abstract][Full Text] [Related]
18. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.
Lagast H; Pascual-Lopez A; Dejace P; Klastersky J
Eur J Clin Microbiol; 1986 Feb; 5(1):98-102. PubMed ID: 3084248
[TBL] [Abstract][Full Text] [Related]
19. Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa.
Van Laethem Y; Klastersky J
Eur J Clin Microbiol; 1986 Feb; 5(1):110-4. PubMed ID: 3084239
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
Briedis DJ; Robson HG
Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
